Miguel Forte – CEO, Bone Therapeutics, Belgium
Miguel Forte, CEO of Bone Therapeutics, walks through his journey leading the promising Belgian biotech company. He also shares with his view of the Belgian healthcare system and what makes…
Address: Namur Office Park | Avenue des Dessus de Lives, 6 | B-5101 Loyers (Namur)
Tel: +32 81 33 28 50
Web: http://www.investinwallonia.be/?lang=en
Helping foreign investors to successfully set up and integrate their activities as part of the regional economic fabric.
The Foreign Investors division of the Agence Wallonne à l’Exportation et aux Investments étrangers (AWEX) (Walloon Exports and Foreign Investments Agency) is home to a multilingual team of expert consultants who are entirely at your service.
From an initial feasibility study all the way up to signing on the dotted line in concluding the investment, we provide personalised assistance geared to your needs and situation.
If you are a foreign investor looking to develop your activities in Wallonia, you can rest safe in the knowledge that our team of experts is there to assist you every step of the way.
Contact us!
Investor services : the point of single contact for all aspiring foreign investors seeking to set up business in Wallonia.
Our remit is:
to help you in seeking out appropriate sites and premises;to provide assistance with the start-up, development and diversification of your business;
to help you gain access to venture capital;
to provide advice and assistance in attracting suitable human resources;
to help you with setting up training programmes;
to provide assistance in obtaining subsidies from the Regional and European authorities;
to provide legal, tax and logistics support;
Miguel Forte, CEO of Bone Therapeutics, walks through his journey leading the promising Belgian biotech company. He also shares with his view of the Belgian healthcare system and what makes…
Brigitte Nolet, country manager of Roche for Belgium and Luxembourg, speaks about her transition to the Belgian market and her priorities for leading the affiliate. Nolet goes on the elaborate…
Jean Nève and Fabrice Peters, president and general coordinator of the Belgian Superior Health Council (SHC), introduce the organization, elaborate on its role in helping guide the country’s healthcare policy,…
Bertrand Duquesne, managing director of Boiron Belgium, elaborates on the challenges being faced by homeopathy manufacturers in western Europe and explains how the company and its peers are create dialogue…
Vincent Verschraegen, country manager of Mylan Belgium and Luxembourg, speaks about his onboarding in the company and what attracted him to join the organization. Verschraegen also discusses Mylan’s evolution from…
PDC*Line Pharma’s Eric Halioua introduces the Belgian immuno-oncology biotech, its clinical-stage assets, the impact of the firm’s collaboration with Korean LG Chem, and future internationalisation strategies. As a multicultural…
Miranda Heining, general manager of Fresenius Kabi for Belgium and the Netherlands, speaks about the career path that led her to join the pharma industry and lead the affiliate, her…
Christos Andriopoulos, managing director of Merck, speaks about his experience transitioning from global operations to leading a country subsidiary. Andriopoulos goes on to explain the company’s unique positioning as an…
Fréderic Covemaeker, general manager of Nordic Pharma Belgium, introduces the Belgian affiliate which he established himself in 2008 and elaborates on the next stage of development for operations as Nordic…
Despite a population size of only 11.4 million (ninth in Europe), Belgium is the continent’s fifth biggest spender on R&D, behind only Germany, Switzerland, the UK, and France according to…
Xavier De Cuyper introduces the Federal Agency for Medicines & Health Products (FAMHP) and the essential role it plays in Belgium’s healthcare regulatory framework since being founded in 2007. De…
Chantal Depondt, president of the Belgian Neurological Society (BNS), introduces the mission of the professional association and offers her insights into the healthcare and research dynamics surrounding neurological diseases. Depondt…
See our Cookie Privacy Policy Here